Sanofi (SNY) Goodwill & Intangibles (2009 - 2026)

Sanofi (SNY) posted Goodwill & Intangibles of $80.9 billion for Q1 2026, up 2.85% sequentially from $78.6 billion in Q4 2025, and up 20.5% YoY from $67.1 billion in Q1 2025.

Sanofi (SNY) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Sanofi (SNY) has 18 years of Goodwill & Intangibles data on file, last reported at $80.9 billion in Q1 2026.

  • Quarterly Goodwill & Intangibles rose 20.5% year-over-year to $80.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.9 billion (up 20.5% YoY) and the FY2025 annual result came in at $78.6 billion, up 11.49% from the prior year.
  • Goodwill & Intangibles grew to $80.9 billion in Q1 2026 per SNY's latest filing, from $78.6 billion in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $82.6 billion in Q2 2024, with the low at $67.1 billion in Q1 2025.
  • Average Goodwill & Intangibles over 5 years is $76.3 billion, with a median of $78.6 billion recorded in 2025.
  • Year-over-year, Goodwill & Intangibles slipped 16.83% in 2025 and advanced 20.5% in 2026.
  • Sanofi's Goodwill & Intangibles stood at $73.0 billion in 2022, then increased by 8.69% to $79.3 billion in 2023, then retreated by 11.07% to $70.5 billion in 2024, then rose by 11.49% to $78.6 billion in 2025, then climbed by 2.85% to $80.9 billion in 2026.
  • Business Quant data shows SNY's Goodwill & Intangibles at $80.9 billion in Q1 2026, $78.6 billion in Q4 2025, and $80.5 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Sanofi - - 9.49 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 80.88 Bn
Dec 31, 2025 78.64 Bn
Sep 30, 2025 80.51 Bn
Jun 30, 2025 68.73 Bn
Mar 31, 2025 67.12 Bn
Dec 31, 2024 70.54 Bn
Jun 30, 2024 82.63 Bn
Dec 31, 2023 79.32 Bn
Jun 30, 2023 80.40 Bn
Dec 31, 2022 72.98 Bn
Jun 30, 2022 77.40 Bn
Dec 31, 2021 79.46 Bn
Jun 30, 2021 77.61 Bn
Dec 31, 2020 74.86 Bn
Jun 30, 2020 68.59 Bn
Dec 31, 2019 67.62 Bn
Jun 30, 2019 71.37 Bn
Dec 31, 2018 75.47 Bn
Jun 30, 2018 1.20 Bn
Dec 31, 2017 62.81 Bn